Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Novartis buffers price erosion with Cosentyx's 11th FDA nod
Cosentyx is now the first anti-IL-17 approved in polymyalgia rheumatica, a label expansion that could help Novartis stave off price erosion.
Donavyn Coffey
Nov 17, 2026 2:00pm
GSK snags FDA nod for 2nd lung cancer drug from Nuvalent deal
Nov 17, 2026 1:30pm
Digital Twins: Advancing Clinical Evidence Strategy
Brought to you by
IQVIA
AZ emerges victorious in lawsuit over Soliris antitrust claims
Nov 17, 2026 11:25am
Why AI’s Biggest Value in Pharma Is Confidence
Brought to you by
/prompt
Roche’s next major breast cancer drug, Wilserdly, wins FDA nod
Nov 17, 2026 10:50am